M&F Tech

The project 'M&F Tech' (submitted as StarFang) corresponds to a real early-stage biotech entity, 'M&F Tech', working on AI for phage therapy, which addresses a genuine global problem (AMR). However, the submission is riddled with red flags and verifiable falsehoods. The claim that 'most people have used my product' is factually incorrect for a pre-clinical biotech solution. The audience target of 'everyone' demonstrates a lack of market understanding (actual target is B2B/Medical). Financial claims (market cap 500k) are ambiguous and likely misstated. While the underlying technology concept has utility, the poor quality of the response, false traction claims, and lack of verifiable technical evidence result in a score reflecting minimal to no proven traction.